EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure.
V Villanueva, P Bermejo, J Montoya, M Toledo, A Gómez-Ibáñez, M Garcés, L Vilella, F J López-González, X Rodriguez-Osorio, D Campos, P Martínez, P Giner, J Zurita, J Rodríguez-Uranga, J Ojeda, J A Mauri, J L Camacho, J Ruiz-Giménez, J J Poza, A Massot-Tarrús, M L Galiano, M Bonet
Acta neurologica Scandinavica 2018;136(3):254-264